Location: Princeton, NJ ONSITE

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

• HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.

• HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.

• HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

• HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Overview of Role:

The Director, Field Learning & Development (FL&D), is responsible for leading the strategy, development, and execution of training programs for field sales teams and other field-facing commercial functions as needed. The Director FL&D responsibilities include delivery of curriculum for new hire training, brand updates, selling skills, new product launches, POA and National Sales Meetings. This role works closely with senior brand leaders to ensure alignment with brand strategy and brand messaging. Additionally, they will work with Sales Leadership to ensure alignment and effectiveness of training programs that support national, area and regional training needs.

Role and Responsibilities:

• Oversee end-to-end training curriculum, including new hire onboarding, disease-state/clinical content, competitive intelligence, advanced selling capabilities, and ongoing development programs

• Lead the design, development, and deployment of innovative training solutions (in-person, virtual, digital, and blended learning)

• Build frameworks that support product launches, market expansion, and evolving oncology/biotech treatment landscapes

• Partner with Sales, Marketing, Medical Affairs, Market Access and Commercial Operations to ensure all training programs reinforce brand strategy, scientific accuracy, and compliance requirements

• Lead new hire brand training curriculum design, build, implementation

• Partner with senior brand leaders to ensure curriculum alignment

• Ensure all training content adheres to company policies, regulatory requirements, and industry standards

• Partner with senior sales leaders to ensure training effectiveness

• Lead training in tactical and budget planning process for all therapeutic areas

• Ensure field team effectiveness in new hire training responsibilities

• Continuously evaluate FL&D Learning curriculums across brands to ensure effectiveness

• lead special projects including development and implementation of selling model, competency model and new hire curriculum

• All other duties as assigned

Experience, Education and Specialized Knowledge and Skills:

• Bachelors degree required

• Minimum of 10+ years of relevant experience in biotech or pharmaceutical industry, including:

• Minimum of 3+ years of pharmaceutical sales experience

• Minimum of 5+ years of Commercial Learning leadership experience

• Proven track record leading commercial training, field development, or sales effectiveness initiatives

• Experience in oncology/hematology

• Strong leadership experience in Oncology (Lung Cancer preferred) training including curriculum design and delivery

• Strong understanding of clinical/scientific concepts, competitive landscapes, and oncology treatment paradigms

• Demonstrated ability to lead teams, influence senior leaders, and manage complex cross-functional initiatives

• Exceptional communication, facilitation, and strategic planning skills

• Demonstrated people leadership experience managing various levels of Learning professionals

The pay range for this role is $190,000-$237,000 annually. Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.